Adaptive mutations resulting in enhanced polymerase activity contribute to high virulence of influenza A virus in mice
Related Experiment Video
Updated: Jun 23, 2026

Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies
Published on: August 29, 2017
Thierry Rolling1, Iris Koerner, Petra Zimmermann
1Department of Virology, University of Freiburg, Hermann-Herder-Strasse 11, 79104 Freiburg, Germany.
Abstract:
High virulence of influenza virus A/Puerto Rico/8/34 in mice carrying the Mx1 resistance gene was recently shown to be determined by the viral surface proteins and the viral polymerase. Here, we demonstrated high-level polymerase activity in mammalian host cells but not avian host cells and investigated which mutations in the polymerase subunits PB1, PB2, and PA are critical for increased polymerase activity and high virus virulence. Mutational analyses demonstrated that an isoleucine-to-valine change at position 504 in PB2 was the most critical and strongly enhanced the activity of the reconstituted polymerase complex. An isoleucine-to-leucine change at position 550 in PA further contributed to increased polymerase activity and high virulence, whereas all other mutations in PB1, PB2, and PA were irrelevant. To determine whether this pattern of acquired mutations represents a preferred viral strategy to gain virulence, two independent new virus adaptation experiments were performed. Surprisingly, the conservative I504V change in PB2 evolved again and was the only mutation present in an aggressive virus variant selected during the first adaptation experiment. In contrast, the virulent virus selected in the second adaptation experiment had a lysine-to-arginine change at position 208 in PB1 and a glutamate-to-glycine change at position 349 in PA. These results demonstrate that a variety of minor amino acid changes in the viral polymerase can contribute to enhanced virulence of influenza A virus. Interestingly, all virulence-enhancing mutations that we identified in this study resulted in substantially increased viral polymerase activity.
Insights
Minor mutations in influenza A virus polymerase subunits PB1, PB2, and PA can significantly increase viral virulence. Specific changes, like isoleucine-to-valine at PB2 position 504, enhance polymerase activity and virus pathogenicity.
Area of Science:
- Virology
- Molecular Biology
- Immunology
Background:
- Influenza A virus virulence is influenced by viral surface proteins and polymerase.
- The Mx1 resistance gene in mice affects influenza A virus virulence.
- Understanding polymerase function is key to controlling viral pathogenicity.
Purpose of the Study:
- Identify critical mutations in influenza A virus polymerase subunits (PB1, PB2, PA) that enhance polymerase activity and virulence.
- Investigate if specific mutations are preferred viral strategies for gaining virulence.
- Determine the impact of identified mutations on polymerase activity in different host cells.
Main Methods:
- Mutational analysis of influenza A virus polymerase subunits (PB1, PB2, PA).
- Reconstitution of polymerase complexes and assessment of activity in mammalian and avian host cells.
- Virus adaptation experiments to select for virulent variants.
Main Results:
- An isoleucine-to-valine change at position 504 in PB2 was critical for enhanced polymerase activity and virulence.
- An isoleucine-to-leucine change at position 550 in PA further contributed to increased activity and virulence.
- Two independent adaptation experiments revealed different mutation patterns, including the recurrent I504V change in PB2, and novel mutations in PB1 and PA.
Conclusions:
- A variety of minor amino acid changes in the viral polymerase can significantly enhance influenza A virus virulence.
- All identified virulence-enhancing mutations led to substantially increased viral polymerase activity.
- Specific mutations in PB2 and PA play crucial roles in determining influenza A virus virulence.
Related Concept Videos
Viral Mutations
Leaky Scanning
Influenza
Inhibitors Of Virion Release
Mutations in Microorganisms
Viral Recombination

